Award
Delivery Order #SPE2DR26F41B9
AmerisourceBergen Awarded Delivery Order for Antibiotic Medication
Buyer
Defense Logistics Agency
Award Amount
$20.30
Ceiling
$20.30
Awarded
March 03, 2026
Period of Performance
Mar 03, 2026 – Mar 04, 2026
Identifier
SPE2DR26F41B9
NAICS
424210
This award represents a definite delivery order under a larger indefinite delivery/indefinite quantity (IDIQ) contract for pharmaceutical supplies. The contract was granted to AmerisourceBergen Drug Corporation, a leading pharmaceutical distribution company responsible for ensuring the availability of essential medications to government healthcare agencies. Specifically, this delivery order is for Amoxicillin-Clavulanate Suspension, an important antibiotic treatment. This procurement is significant as it supports the agency's commitment to public health by maintaining a reliable supply of critical medicines. The scope of work includes the timely delivery of the specified pharmaceutical product to the designated location in Conshohocken, PA. The delivery order was awarded through the existing IDIQ contract, indicating a non-competitive continuation under an established agreement. The procurement activity occurred within a concise timeframe, reflecting the need for prompt fulfillment of medical supply requirements. This order stems from the parent long-term contract, which secures AmerisourceBergen's role as a key pharmaceutical supplier over multiple years, ensuring sustained support for the agency's healthcare operations.
Description
4571018921!AMOX-CLAV 600-42.9 MG/5 ML SUS 125ML